People news: Par Pharmaceutical

Par Pharmaceutical Companies said John MacPhee had resigned as president of Strativa Pharmaceuticals and EVP Par Pharmaceutical “to pursue other interests” after six years with the company. Day-to-day oversight of Strativa, the company's proprietary products division, will be assumed by Par chairman, president and CEO Patrick LePore on an interim basis. Woodcliff Lake, NJ-based Par's focus is on marketing higher-barrier-to-entry generics and niche, innovative branded drugs.
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.